John E. Harlan
4Patents
2h-index
23Co-inventors
44Inventor score
Filing activity: Nov 30, 2006 → Jan 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8323651B2 | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof | Emerging Cross-Sectional Technologies | 28 | Active |
| US8263558B2 | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | Human Necessities | 20 | Active |
| US9394363B2 | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11759527B2 | Anti-EGFR antibody-drug conjugates | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.